Brief: Veracyte's Percepta Genomic Sequencing Classifier Can Help Accelerate Timely Treatment For Patients With Early-Stage Lung Cancer

Veracyte

24/01/2022 14:52

Jan 24 (Reuters) - Veracyte Inc  VCYT.O :
    * NEW DATA SUGGEST VERACYTE’S PERCEPTA GENOMIC SEQUENCING
CLASSIFIER CAN HELP ACCELERATE TIMELY TREATMENT FOR PATIENTS
WITH EARLY-STAGE LUNG CANCER
    * VERACYTE - FINDINGS SHOW GENOMIC TEST'S EXPANDED CLINICAL
UTILITY IN EVALUATING PATIENTS WITH LUNG NODULES WHOSE
BRONCHOSCOPY RESULTS ARE INCONCLUSIVE

Source text for Eikon:  ID:nBw6Z0HMGa 
Further company coverage:  VCYT.O 

 ((Reuters.Briefs@thomsonreuters.com;))